Hepatocellular Carcinoma: Risk Factors and Diagnosis
DOI:
10.29303/jbt.v23i1.5750Published:
2023-11-08Downloads
Abstract
Hepatocellular carcinoma, also known as hepatocarcinoma, is the most frequent type of primary liver cancer and the world's second leading cause of death, with a mortality rate of 700.000 per year. Due to the difficulty in diagnosing hepatocarcinoma because there are no obvious symptoms, the survival rate of hepatocarcinoma patients is still very low, particularly in Southeast Asian countries. Hepatocarcinoma is still a major health issue in Indonesia, with a very low median survival rate. The number of risk factors that cause hepatocarcinoma is what causes differences in hepatocarcinoma incidence across countries. This literature review aims to determine risk factors and to confirm the diagnosis of hepatocarcinoma. This literature review was conducted using the keywords “Hepatocellular Carcinoma AND risk factors AND diagnosis” from PubMed, Google Scholar, and non-peer-reviewed literature. This article uses 16 articles that were used as references in its preparation. In conclusion, hepatitis B and C virus, liver cirrhosis, fatty liver disease, diabetes, alcohol use, aflatoxin exposure, aristolochic acid exposure, smoking, and HIV are risk factors for hepatocarcinoma. On all individuals with hepatocarcinoma risk factors, screening procedures with US and AFP were carried out. An abdominal CT scan or an MRI with contrast can both be used to provide a firm diagnosis of hepatocarcinoma. A liver biopsy is used to confirm the diagnosis of space-occupying lesions that lack typical imaging characteristics.
Keywords:
Diagnosis, hepatocarcinoma, risk factors.References
Charach, L., Zusmanovitch, L., & Charach, G. (2017). Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology. EMJ Hepatology, 5(1), 75–80. URL: https://emj.europeanmedical-group.com/wp-content/uploads/sites/2/2017/11/Editors-Pick-Hepatocellular-Carcinoma.-Part-1-Epidemiology-Risk-Factors-Pathogenesis-and-Pathology.pdf
Chedid, M. F., Kruel, C. R. P., Pinto, M. A., Grezzana-Filho, T. J. M., Leipnitz, I., Kruel, C. D. P., Scaffaro, L. A., & Chedid, A. D. (2017). Hepatocellular Carcinoma: Diagnosis And Operative Management. Abcd Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 30(4), 272–278. DOI: https://doi.org/10.1590/0102-6720201700040011
Forner, A., Reig, M., & Bruix, J. (2018). Hepatocellular carcinoma. The Lancet, 391(10127), 1301–1314. DOI: https://doi.org/10.1016/S0140-6736(18)30010-2
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J. L., Schirmacher, P., & Vilgrain, V. (2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology, 69(1), 182–236. DOI: https://doi.org/10.1016/j.jhep.2018.03.019
Gani, R. A. (2017). Hepatocellular Carcinoma (HCC) Surveillance – Comprehensive Management in Liver Cirrhosis Patients. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 18(3), 137–139. DOI: https://doi.org/10.24871/1832017137-139
Ghouri, Y., Mian, I., & Rowe, J. (2017). Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. Journal of Carcinogenesis, 16(1), 1–8. DOI: https://doi.org/10.4103/jcar.JCar_9_16
Gomez-Quiroz, L. E., & Roman, S. (2022). Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Annals of Hepatology, 27, 100649. DOI: https://doi.org/10.1016/j.aohep.2021.100649
Jasirwan, C. O. M., Hasan, I., Sulaiman, A. S., Lesmana, C. R. A., Kurniawan, J., Kalista, K. F., Nababan, S. H., & Gani, R. A. (2020). Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia. Current Problems in Cancer, 44(1), 100480. DOI: https://doi.org/10.1016/j.currproblcancer.2019.05.003
Kulik, L., & El-Serag, H. B. (2019). Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology, 156(2), 477-491.e1. DOI: https://doi.org/10.1053/j.gastro.2018.08.065
Papadakis, M. A., McPhee, S. J., & Rabow, M. W. (2019). CURRENT Medical Diagnosis & Treatment (58th ed.). McGraw-Hill Education.
Sahu, S. K., Chawla, Y. K., Dhiman, R. K., Singh, V., Duseja, A., Taneja, S., Kalra, N., & Gorsi, U. (2019). Rupture of Hepatocellular Carcinoma: A Review of Literature. Journal of Clinical and Experimental Hepatology, 9(2), 245–256. DOI: https://doi.org/10.1016/j.jceh.2018.04.002
Sciancalepore, D., Zingaro, M. T., Luglio, C. V., Sabbà, C., & Napoli, N. (2018). Hepatocellular Carcinoma: Known and Emerging Risk Factors. Journal of Cancer Therapy, 09(05), 417–437. DOI: https://doi.org/10.4236/jct.2018.95037
Shi, L., Qu, Z., Yang, Y., Zhang, Y., & Sun, D. (2022). Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine, 2022. DOI: https://doi.org/10.1155/2022/8195512
Villanueva, A. (2019). Hepatocellular Carcinoma. New England Journal of Medicine, 380(15), 1450–1462. DOI: https://doi.org/10.1056/NEJMra1713263
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019). A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology, 16(10), 589–604. DOI: https://doi.org/10.1038/s41575-019-0186-y
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Han, G., Wang, M., Liu, R., Lu, L., Ren, Z., Chen, M., Zeng, Z., Liang, P., Liang, C., … Fan, J. (2020). Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer, 9(6), 682–720. DOI: https://doi.org/10.1159/000509424
License
Copyright (c) 2023 Ghina Syafinatunnajah, Ananda Rizkia, Donna Diva Widyantari, Ni Pt Wr Pradnya Nirmala Putri, Catarina Budyono
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
